stars 1 stars 2 stars 3

View Prolival's top competitors like AstraZeneca France SAS, BIOGARAN, and CERBA HEALTHCARE.

Pierre Fabre Group
💊🔬 Laboratoires Pierre Fabre is theworld’ssecond-largest dermo-cosmetics company and one ofEurope’sleading pharmaceuticallaboratories. ItsDermo-cosmetics & Personal Careportfolio brings together major international brands such as EauThermaleAvène,Dexeryl,Ducray,Klorane,A-Derma, RenéFurterer,MêmeCosmetics,Darrow, andElgydium. The Pharma activity covers5main therapeutic fields: oncology, dermatology,rare diseases,primarycareand family health care. In 2025, Laboratoires Pierre Fabre generated €3.2 billion euros in revenue, 71% of which came from international sales across 130 territories. Based in southwest France since its creation and manufacturingnearly90%of its products in France, Laboratoires Pierre Fabre employs 10,000 people worldwide. R&D investments increased by 14% compared with the previous year, reaching €250 million, 67% of which is dedicated to targeted therapies in oncology. The majority shareholder of Laboratoires Pierre Fabre is the Pierre Fabre Foundation (holding 86.3% of the capital), a humanitarian foundation recognized as being of public utility. The company’s employees are its second-largest shareholder (nearly 10%). This shareholding structure guarantees the company’s independence, its long-term vision and its sustainable contribution to the common good. Dividends paid to the Pierre Fabre Foundation contribute to 43 healthcare-access projects deployed in 25 of the least developed countries in the world. Since 2022, Laboratoires Pierre Fabre’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development).
Toulouse, FR
Private
$300M Revenue
https://www.pierre-fabre.com
9.8K Employees
Ipsen
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.
Paris, FR
Public
$3.7B Revenue
http://www.ipsen.com
6.7K Employees
IPN Ticker
STADA APAC
STADA Pharmaceuticals Asia Ltd is a pharmaceutical trading company and the APAC Regional Headquarters for STADA Arzneimittel AG, Headquarter based in Germany. We at STADA Pharmaceuticals Asia Ltd are devoted as a healthcare service provider to the APAC region, with subsidiaries in selected key markets such as Australia, China, Philippines, and Thailand, as well as a network of trusted, independent partner companies. As part of the STADA Arzneimittel AG, we follow our group purpose of “Caring for People’s Health as a Trusted Partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In financial year 2021, STADA achieved group sales of EUR 3,249.5 million and reported earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 776.5 million. As of 31 December 2021, STADA employed 12,520 people worldwide.
HK
Private
$3.1B Revenue
https://www.stada.com/
11 Employees
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users